McLatchie L M, Young J S, Fry C H
Department of Biochemistry and Physiology, FHMS, University of Surrey, Guildford, UK.
Br J Pharmacol. 2014 Jul;171(14):3394-403. doi: 10.1111/bph.12682.
The aim of this study was to quantify and characterize the mechanism of non-neuronal ACh release from bladder urothelial cells and to determine if urothelial cells could be a site of action of anti-muscarinic drugs.
A novel technique was developed whereby ACh could be measured from freshly isolated guinea pig urothelial cells in suspension following mechanical stimulation. Various agents were used to manipulate possible ACh release pathways in turn and to study the effects of muscarinic receptor activation and inhibition on urothelial ATP release.
Minimal mechanical stimulus achieved full ACh release, indicating a small dynamic range and possible all-or-none signal. ACh release involved a mechanism dependent on the anion channel CFTR and intracellular calcium concentration, but was independent of extracellular calcium, vesicular trafficking, connexins or pannexins, organic cation transporters and was not affected by botulinum-A toxin. Stimulating ACh receptors increased ATP production and antagonizing them reduced ATP release, suggesting a link between ACh and ATP release.
These results suggest that release of non-neuronal ACh from the urothelium is large enough and well located to act as a modulator of ATP release. It is hypothesized that this pathway may contribute to the actions of anti-muscarinic drugs in reducing the symptoms of lower urinary tract syndromes. Additionally the involvement of CFTR in ACh release suggests an exciting new direction for the treatment of these conditions.
本研究旨在量化并描述膀胱尿路上皮细胞非神经元性乙酰胆碱(ACh)释放的机制,并确定尿路上皮细胞是否可能是抗毒蕈碱药物的作用位点。
开发了一种新技术,通过该技术可在机械刺激后,从新鲜分离的豚鼠悬浮尿路上皮细胞中测量ACh。依次使用各种试剂来操纵可能的ACh释放途径,并研究毒蕈碱受体激活和抑制对尿路上皮ATP释放的影响。
最小的机械刺激可实现ACh的完全释放,表明其动态范围较小且可能存在全或无信号。ACh释放涉及一种依赖于阴离子通道CFTR和细胞内钙浓度的机制,但与细胞外钙、囊泡运输、连接蛋白或泛连接蛋白、有机阳离子转运体无关,且不受肉毒杆菌A毒素影响。刺激ACh受体会增加ATP生成,而拮抗它们则会减少ATP释放,这表明ACh与ATP释放之间存在联系。
这些结果表明,尿路上皮非神经元性ACh的释放量足够大且定位良好,足以作为ATP释放的调节剂。据推测,该途径可能有助于抗毒蕈碱药物减轻下尿路综合征症状的作用。此外,CFTR参与ACh释放为这些病症的治疗提示了一个令人兴奋的新方向。